Study of GLP-1 medicines after weight loss surgery
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are planning to have weight loss surgery at the University of Missouri Health Care
- Your body mass index (BMI) is between 30 and 80
- You are currently taking a GLP-1 medication (like Ozempic, Wegovy, or Mounjaro) as part of your regular care
- You're willing to have your blood drawn and your medical data collected for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to see how GLP-1 RA medications (like Ozempic) affect the stomach in people with type 2 diabetes and obesity. It may help doctors better understand how these medicines work.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
This study looks at how taking a GLP-1 medicine (like Ozempic or Wegovy) affects your fat tissue before bariatric surgery. It compares people who have taken a GLP-1 for at least 3 months to those who never have.
This study tests whether a GLP-1 medication (like Ozempic) can help people with obesity who are having hip or knee replacement surgery. It aims to see if the medication improves recovery and outcomes.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.